ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

IndiaMART working with Novo Nordisk to halt illegal Wegovy sales: Report
IndiaMART, one of India's top online marketplaces, allows dealers to sell on its website after a nominal background check and says it has minimal control over what is advertised and sold
Announcement as on 18 December 2023

Novo Nordisk to invest over .01B to boost production, including GLP-1 drugs
Novo Nordisk to invest over .01B to boost production, including GLP-1 drugs
Announcement as on 10 November 2023

Why Novo Nordisk Stock Flopped on Friday
A post-earnings price target raise on Novo Nordisk (NYSE: NVO) from an analyst couldn't overcome the drag of a executive's stock sale on Friday. Ultimately, investors ended up trading out of the Danish pharmaceutical company, sending its share price down b
Announcement as on 03 November 2023

Novo Nordisk gets approval to carry out clinical trials on weekly insulin
Novo Nordisk has received approval from the Drug Controller General of India to conduct phase-III studies for its new weekly insulin injection, IcoSema, in India. IcoSema is a combination of insulin and Semaglutide and is meant to control blood sugar level
Announcement as on 20 October 2023

Novo Nordisk (NVO) Raises Sales Outlook for 2023, Shares Gain
Novo Nordisk NVO upped its sales and operating profit forecast for 2023 yet again on the back of higher demand for diabetes drug Ozempic (semaglutide) and obesity drug Wegovy. 
Announcement as on 16 October 2023

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 37.7
  • 12Day Average: 38.77
  • 20Day Average: 40.65
  • 50Day Average: 44.46
  • 100Day Average: 45.41
  • 150Day Average: 43.57
  • 200Day Average: 45.65

NVO Indicators & signals

Indicator MACD (12,26,9)

38.97, 41.13, -1.98
Indicator MACD is in negative zone

Indicator ADX (14)

50, 13.79, 41.38
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 47
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Mon Oct 2026 37.56 36.46 to 37.76 0.64% 0.64 times
02 Fri Oct 2026 37.32 37.17 to 37.65 -0.24% 0.61 times
01 Thu Oct 2026 37.41 37.37 to 38.15 -1.32% 0.55 times
30 Wed Sep 2026 37.91 37.89 to 38.77 -1.04% 1.28 times
29 Tue Sep 2026 38.31 38.05 to 38.38 -1.03% 0.56 times
28 Mon Sep 2026 38.71 38.23 to 38.90 -0.21% 0.68 times
25 Fri Sep 2026 38.79 38.41 to 38.88 0.41% 0.45 times
24 Thu Sep 2026 38.63 37.61 to 38.72 1.21% 0.87 times
23 Wed Sep 2026 38.17 38.16 to 39.14 -3.12% 1.1 times
22 Tue Sep 2026 39.40 39.11 to 39.89 -1.05% 1.45 times
21 Mon Sep 2026 39.82 39.54 to 43.72 -7.91% 2.44 times
18 Fri Sep 2026 43.24 42.78 to 43.54 0.12% 0.62 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top